APOL4 | Apolipoprotein L, 4 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ARSD | Arylsulfatase D | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | Blood group antigen proteins CD markers Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ATP13A1 | ATPase type 13A1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5G2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BACE2 | Beta-site APP-cleaving enzyme 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BCAM | Basal cell adhesion molecule (Lutheran blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BDNF | Brain-derived neurotrophic factor | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BOC | BOC cell adhesion associated, oncogene regulated | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BTN2A1 | Butyrophilin, subfamily 2, member A1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A1 | Butyrophilin, subfamily 3, member A1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A2 | Butyrophilin, subfamily 3, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C11orf24 | Chromosome 11 open reading frame 24 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C12orf76 | Chromosome 12 open reading frame 76 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C16orf52 | Chromosome 16 open reading frame 52 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf85 | Chromosome 1 open reading frame 85 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C3orf33 | Chromosome 3 open reading frame 33 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
C6orf25 | Chromosome 6 open reading frame 25 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C7orf69 | Chromosome 7 open reading frame 69 | Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA2D1 | Calcium channel, voltage-dependent, alpha 2/delta subunit 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CACNA2D4 | Calcium channel, voltage-dependent, alpha 2/delta subunit 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CALCRL | Calcitonin receptor-like | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CAMK2D | Calcium/calmodulin-dependent protein kinase II delta | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CASD1 | CAS1 domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CATSPERG | Catsper channel auxiliary subunit gamma | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CCL5 | Chemokine (C-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CD164 | CD164 molecule, sialomucin | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD164L2 | CD164 sialomucin-like 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD1E | CD1e molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |